| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.02.
| Jubilant und Endo Pharmaceuticals geben vorzeitiges Erreichen eines Meilensteins im Rahmen eines gemeinsamen Forschungsprogramms bekannt | | 70 | news aktuell |
| Bangalore, Indien (ots/PRNewswire) - Jubilant Biosys Ltd., eine in Bangalore ansässige Tochterfirma der Jubilant Life Sciences Ltd., gab heute bekannt, im Rahmen eines ihrer gemeinsamen Forschungsprogramme...
Mehr lesen zu:
Jubilant und Endo Pharmaceuticals geben vorzeitiges Erreichen eines Meilensteins im Rahmen eines gemeinsamen Forschungsprogramms bekannt | |
| 09.02.
| Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative Discovery Program | | 46 | PR Newswire |
| BANGALORE, India, February 9, 2012 /PRNewswire/ --
Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced today that they have achieved an early stagemilestone...
Mehr lesen zu:
Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative Discovery Program | |
| 06.02.
| 2012 Economic Outlook - Report Highlights Bed Bath & Beyond Inc. and Endo Pharmaceuticals | | 12 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/06/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Bed Bath & Beyond Inc. (NASDAQ: BBBY) and Endo Pharmaceuticals (NASDAQ: ENDP). Gain market...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Bed Bath & Beyond Inc. and Endo Pharmaceuticals | |
| 06.02.
| A Forward Look, the Year Ahead - Featured Research on Sanofi SA (ADR) and Endo Pharmaceuticals | | 31 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/06/12 -- Today, www.BollingerReport.com introduced featured coverage of Sanofi SA (ADR) (NYSE: SNY) and Endo Pharmaceuticals (NASDAQ: ENDP). Full research reports are...
Mehr lesen zu:
A Forward Look, the Year Ahead - Featured Research on Sanofi SA (ADR) and Endo Pharmaceuticals | |
| 03.02.
| Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2011 Financial Results on February 24, 2012 | | 15 | PR Newswire |
| CHADDS FORD, Pa., Feb. 3, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) will announce its fourth quarter and full year 2011 financial results on February 24, 2012...
Mehr lesen zu:
Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2011 Financial Results on February 24, 2012 | |
| 01.02.
| Risk-Reward Balances for Endo Pharma | | - | Zacks |
| 31.01.
| Endo Pharmaceuticals Shares Up 27.8% Since SmarTrend's Buy Recommendation | | - | SmarTrend |
| 30.01.
| Endo Pharmaceuticals Bearish Moving Average Crossover Alert | | - | SmarTrend |
| 26.01.
| Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. | | 26 | PR Newswire |
| CHICAGO, Jan. 25, 2012 /PRNewswire/ -- Stocks in this week's article include: Akorn, Inc. (NASDAQ: AKRX), Diana Shipping Inc. (NYSE: DSX), Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), Southwest...
Mehr lesen zu:
Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. | |
| 18.01.
| PA Governor Corbett Visits Future Site of Endo Pharmaceuticals HQ; Praises Company for its Continued Commitment to Pennsylvania | | 47 | PR Newswire |
| MALVERN, Pa., Jan. 17, 2012 /PRNewswire-USNewswire/ -- Governor Tom Corbett today visited the future site of Endo Pharmaceutical's corporate headquarters in Chester County, where he...
Mehr lesen zu:
PA Governor Corbett Visits Future Site of Endo Pharmaceuticals HQ; Praises Company for its Continued Commitment to Pennsylvania | |
| 10.01.
| Bullish Moving Average Cross by Endo Pharmaceuticals | | 1 | SmarTrend |
| 09.01.
| Notable Put Options Activity in Endo Pharmaceuticals | | - | Benzinga.com |
| 09.01.
| XFRA EPV: WIEDERAUFNAHME/RESTART | | 60 | Xetra Newsboard |
| DIE FOLGENDE AKTIE WIRD MIT SOFORTIGER WIRKUNG WIEDER IN DEN HANDEL AUFGENOMMEN: THE FOLLOWING SHARE IS RESUMED TRADING WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN Endo PHARMS EPV...
Mehr lesen zu:
XFRA EPV: WIEDERAUFNAHME/RESTART | |
| 09.01.
| XFRA EPV: AUSSETZUNG/SUSPENSION | | 90 | Xetra Newsboard |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT: THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ENDO PHARMS HLDGS EPV US29264F2056 BAW/UFN
Mehr lesen zu:
XFRA EPV: AUSSETZUNG/SUSPENSION | |
| 09.01.
| Endo Pharma (ENDP) Sees Supply Constraint on OPANA ER w/ Recent Facility Shutdown | | - | StreetInsider.com |
| 09.01.
| Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility | | 19 | PR Newswire |
| CHADDS FORD, Pa., Jan. 9, 2012 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln,...
Mehr lesen zu:
Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility | |
| 06.01.
| Endo Pharmaceuticals New Coverage Alert, Watch for 18.4% Technical Uptrend Continuation | | - | SmarTrend |
| 06.01.
| Endo Pharma Signs License And Development Deal For BEMA Drug Candidate | | 92 | AFX News |
| WASHINGTON (dpa-AFX) - Endo Pharmaceuticals (ENDP) Friday said it has signed
a global license and development agreement with BioDelivery Sciences
International, a pharma company based in...
Mehr lesen zu:
Endo Pharma Signs License And Development Deal For BEMA Drug Candidate | |
| 06.01.
| BioDelivery (BDSI), Endo (ENDP) Enter BEMA Buprenorphine License Agreement; $180M Potential for BioDelivery | | 2 | StreetInsider.com |
| 06.01.
| BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine | | 80 | PR Newswire |
| RALEIGH, N.C., Jan. 6, 2012 /PRNewswire/ --BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals...
Mehr lesen zu:
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine | |
